Kannalife | Dean Petkanas

Share:

Listens: 0

Raising Cannabis Capital

Business


   Improving CBD’s aptitude to create a new treatment for patients with significant medical needs. The medical benefits of Cannabidiol (CBD) were most notably confirmed in the U.S. Government Patent 6,630,507 – “Cannabinoids as Antioxidants and Neuroprotectants”.    Kannalife (OTCMKTS: KLFE) received a license to use the patent to conduct research on cannabinoid therapeutics.   Dean Petkanas  speaks to Dan Humiston about their discoveries for the treatment of Chemotherapy Induced Peripheral Neuropathy (CIPN), Hepatic Encephalopathy (HE), Mild Traumatic Brain Injury (mTBI) and chronic pain management.Produced by PodCONX